APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L207. A total of 27 filers reported holding APTEVO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,334,169 | $440,276 | 0.32% |
| ARMISTICE CAPITAL, LLC | 1,235,000 | $407,550 | 0.01% |
| Divergent Wealth Advisors | 10,000 | $3,300 | 0.00% |
| FIFTH THIRD BANCORP | 291 | $96 | 0.00% |
| FRANKLIN RESOURCES INC | 10,997 | $3,629 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 6 | $2 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 142 | $47 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,562 | $515 | 0.00% |
| NORTHERN TRUST CORP | 14,121 | $4,660 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 75,355 | $24,867 | 0.00% |
| STATE STREET CORP | 10,941 | $3,611 | 0.00% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 46,200 | $16 | 0.00% |
| CITIGROUP INC | 10 | $3 | 0.00% |
| MORGAN STANLEY | 11,013 | $3,634 | 0.00% |
| BlackRock Inc. | 47,668 | $15,731 | 0.00% |
| Truvestments Capital LLC | 95 | $31 | 0.00% |
| Tower Research Capital LLC (TRC) | 13,495 | $4,453 | 0.00% |
| JPMORGAN CHASE & CO | 1,907 | $629 | 0.00% |
| Renaissance Technologies | 175,980 | $58 | 0.00% |
External links
This page lists APTEVO THERAPEUTICS INC's shareholders in Q3 2023. To view APTEVO THERAPEUTICS INC's shareholder history, click here.